TY - JOUR
T1 - Divergent age-associated and metabolism-associated gut microbiome signatures modulate cardiovascular disease risk
AU - Wang, Tiange
AU - Shi, Zhun
AU - Ren, Huahui
AU - Xu, Min
AU - Lu, Jieli
AU - Yang, Fangming
AU - Ye, Chaojie
AU - Wu, Kui
AU - Chen, Mingling
AU - Xu, Xun
AU - Liu, Dong
AU - Kong, Lijie
AU - Zheng, Ruizhi
AU - Zheng, Jie
AU - Li, Mian
AU - Xu, Yu
AU - Zhao, Zhiyun
AU - Chen, Yuhong
AU - Yang, Huanming
AU - Wang, Jian
AU - Ning, Guang
AU - Li, Junhua
AU - Zhong, Huanzi
AU - Bi, Yufang
AU - Wang, Weiqing
N1 - Publisher Copyright:
© The Author(s), under exclusive licence to Springer Nature America, Inc. 2024.
PY - 2024/6
Y1 - 2024/6
N2 - Insight into associations between the gut microbiome with metabolism and aging is crucial for tailoring interventions to promote healthy longevity. In a discovery cohort of 10,207 individuals aged 40–93 years, we used 21 metabolic parameters to classify individuals into five clusters, termed metabolic multimorbidity clusters (MCs), that represent different metabolic subphenotypes. Compared to the cluster classified as metabolically healthy (MC1), clusters classified as ‘obesity-related mixed’ (MC4) and ‘hyperglycemia’ (MC5) exhibited an increased 11.1-year cardiovascular disease (CVD) risk by 75% (multivariable-adjusted hazard ratio (HR): 1.75, 95% confidence interval (CI): 1.43–2.14) and by 117% (2.17, 1.72–2.74), respectively. These associations were replicated in a second cohort of 9,061 individuals with a 10.0-year follow-up. Based on analysis of 4,491 shotgun fecal metagenomes from the discovery cohort, we found that gut microbial composition was associated with both MCs and age. Next, using 55 age-specific microbial species to capture biological age, we developed a gut microbial age (MA) metric, which was validated in four external cohorts comprising 4,425 metagenomic samples. Among individuals aged 60 years or older, the increased CVD risk associated with MC4 or MC5, as compared to MC1, MC2 or MC3, was exacerbated in individuals with high MA but diminished in individuals with low MA, independent of age, sex and other lifestyle and dietary factors. This pattern, in which younger MA appears to counteract the CVD risk attributable to metabolic dysfunction, implies a modulating role of MA in cardiovascular health for metabolically unhealthy older people.
AB - Insight into associations between the gut microbiome with metabolism and aging is crucial for tailoring interventions to promote healthy longevity. In a discovery cohort of 10,207 individuals aged 40–93 years, we used 21 metabolic parameters to classify individuals into five clusters, termed metabolic multimorbidity clusters (MCs), that represent different metabolic subphenotypes. Compared to the cluster classified as metabolically healthy (MC1), clusters classified as ‘obesity-related mixed’ (MC4) and ‘hyperglycemia’ (MC5) exhibited an increased 11.1-year cardiovascular disease (CVD) risk by 75% (multivariable-adjusted hazard ratio (HR): 1.75, 95% confidence interval (CI): 1.43–2.14) and by 117% (2.17, 1.72–2.74), respectively. These associations were replicated in a second cohort of 9,061 individuals with a 10.0-year follow-up. Based on analysis of 4,491 shotgun fecal metagenomes from the discovery cohort, we found that gut microbial composition was associated with both MCs and age. Next, using 55 age-specific microbial species to capture biological age, we developed a gut microbial age (MA) metric, which was validated in four external cohorts comprising 4,425 metagenomic samples. Among individuals aged 60 years or older, the increased CVD risk associated with MC4 or MC5, as compared to MC1, MC2 or MC3, was exacerbated in individuals with high MA but diminished in individuals with low MA, independent of age, sex and other lifestyle and dietary factors. This pattern, in which younger MA appears to counteract the CVD risk attributable to metabolic dysfunction, implies a modulating role of MA in cardiovascular health for metabolically unhealthy older people.
UR - https://www.scopus.com/pages/publications/85195311000
U2 - 10.1038/s41591-024-03038-y
DO - 10.1038/s41591-024-03038-y
M3 - 文章
C2 - 38844795
AN - SCOPUS:85195311000
SN - 1078-8956
VL - 30
SP - 1722
EP - 1731
JO - Nature Medicine
JF - Nature Medicine
IS - 6
ER -